Goldman Sachs Group »

Gracell Biotechnologies shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $182k 18k 10.04
2023-09-30 $46k 16k 2.88
2023-06-30 $66k 17k 3.81
2023-03-31 $33k 18k 1.86
2022-12-31 $47k 21k 2.30
2022-06-30 $134k 24k 5.52
2022-03-31 $243k 104k 2.33
2021-12-31 $108k 18k 6.03